Shearer, Arran; Bagust, Adrian; Ampudia-Blasco, F.; … - In: PharmacoEconomics 24 (2006) 1, pp. 49-59
<Emphasis Type="Bold">Objective: To assess the lifetime diabetes health consequences and cost-effectiveness in Spain of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in overweight and obese patients failing to maintain glycaemic control with metformin monotherapy compared with...</emphasis>